FAKTOR-ZERTIFIKAT - TANDEM DIABETES CARE Stock

Certificat

DE000JK78D92

Real-time Bid/Ask 06:11:06 2024-06-26 EDT
0.4 EUR / 0.47 EUR +8.75% Intraday chart for FAKTOR-ZERTIFIKAT - TANDEM DIABETES CARE
Current month-99.10%
1 month-98.73%
Date Price Change
24-06-25 0.4 +21.21%
24-06-24 0.33 -72.27%
24-06-21 1.19 +1.71%
24-06-20 1.17 -11.36%
24-06-19 1.32 +3.94%

Delayed Quote Börse Stuttgart

Last update June 25, 2024 at 03:38 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying TANDEM DIABETES CARE, INC.
Issuer J.P. Morgan
WKN JK78D9
ISINDE000JK78D92
Date issued 2024-05-06
Strike 35.99 $
Maturity Unlimited
Parity 11.34 : 1
Emission price 10.14
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 44.8
Lowest since issue 0.33
Spread 0.07
Spread %14.89%

Company Profile

Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.
Sector
-
More about the company

Ratings for Tandem Diabetes Care, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Tandem Diabetes Care, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
40.15 USD
Average target price
49.93 USD
Spread / Average Target
+24.37%
Consensus